259 related articles for article (PubMed ID: 33467194)
1. The Effects of Major Mushroom Bioactive Compounds on Mechanisms That Control Blood Glucose Level.
Aramabašić Jovanović J; Mihailović M; Uskoković A; Grdović N; Dinić S; Vidaković M
J Fungi (Basel); 2021 Jan; 7(1):. PubMed ID: 33467194
[TBL] [Abstract][Full Text] [Related]
2. Exploring Edible Mushrooms for Diabetes: Unveiling Their Role in Prevention and Treatment.
Shamim MZ; Mishra AK; Kausar T; Mahanta S; Sarma B; Kumar V; Mishra PK; Panda J; Baek KH; Mohanta YK
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985818
[TBL] [Abstract][Full Text] [Related]
3. Anti-Diabetic Effects and Mechanisms of Dietary Polysaccharides.
Ganesan K; Xu B
Molecules; 2019 Jul; 24(14):. PubMed ID: 31337059
[TBL] [Abstract][Full Text] [Related]
4. Medicinal mushrooms for glycemic control in diabetes mellitus: history, current status, future perspectives, and unsolved problems (review).
Lo HC; Wasser SP
Int J Med Mushrooms; 2011; 13(5):401-26. PubMed ID: 22324407
[TBL] [Abstract][Full Text] [Related]
5. The Antioxidant Properties of Mushroom Polysaccharides can Potentially Mitigate Oxidative Stress, Beta-Cell Dysfunction and Insulin Resistance.
Arunachalam K; Sreeja PS; Yang X
Front Pharmacol; 2022; 13():874474. PubMed ID: 35600869
[TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of polysaccharides isolated from Astragalus, oyster mushroom, and yacon as inhibitors of α-glucosidase.
Zhu ZY; Zhang JY; Chen LJ; Liu XC; Liu Y; Wang WX; Zhang YM
Chin J Nat Med; 2014 Apr; 12(4):290-3. PubMed ID: 24863354
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of mushrooms in diabetes mellitus: Role of polysaccharides.
Khursheed R; Singh SK; Wadhwa S; Gulati M; Awasthi A
Int J Biol Macromol; 2020 Dec; 164():1194-1205. PubMed ID: 32693144
[TBL] [Abstract][Full Text] [Related]
8. Herbal Medicines for Diabetes Management and its Secondary Complications.
Kumar S; Mittal A; Babu D; Mittal A
Curr Diabetes Rev; 2021; 17(4):437-456. PubMed ID: 33143632
[TBL] [Abstract][Full Text] [Related]
9. Recent Updates on Phytoconstituent Alpha-Glucosidase Inhibitors: An Approach towards the Treatment of Type Two Diabetes.
Kashtoh H; Baek KH
Plants (Basel); 2022 Oct; 11(20):. PubMed ID: 36297746
[TBL] [Abstract][Full Text] [Related]
10. Bioactive Agent Discovery from the Natural Compounds for the Treatment of Type 2 Diabetes Rat Model.
Yang SC; Hsu CY; Chou WL; Fang JY; Chuang SY
Molecules; 2020 Dec; 25(23):. PubMed ID: 33287318
[TBL] [Abstract][Full Text] [Related]
11. Bioactive Compounds in Anti-Diabetic Plants: From Herbal Medicine to Modern Drug Discovery.
Tran N; Pham B; Le L
Biology (Basel); 2020 Aug; 9(9):. PubMed ID: 32872226
[TBL] [Abstract][Full Text] [Related]
12. Effects of Grifola frondosa non-polar bioactive components on high-fat diet fed and streptozotocin-induced hyperglycemic mice.
Shen KP; Su CH; Lu TM; Lai MN; Ng LT
Pharm Biol; 2015 May; 53(5):705-9. PubMed ID: 25431253
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory Effects of Edible and Medicinal Mushrooms and Their Bioactive Immunoregulatory Products.
Zhao S; Gao Q; Rong C; Wang S; Zhao Z; Liu Y; Xu J
J Fungi (Basel); 2020 Nov; 6(4):. PubMed ID: 33171663
[TBL] [Abstract][Full Text] [Related]
14. Bioactive Compounds and Diabetes Mellitus: Prospects and Future Challenges.
Rahman MM; Islam MR; Rabbi F; Islam MT; Sultana S; Ahmed M; Sehgal A; Singh S; Sharma N; Behl T
Curr Pharm Des; 2022; 28(16):1304-1320. PubMed ID: 35418280
[TBL] [Abstract][Full Text] [Related]
15. Mushrooms and Fungi and Their Biological Compounds with Antidiabetic Activity: A Review.
Téllez-Téllez M; Diaz-Godinez G
Int J Med Mushrooms; 2024; 26(5):13-24. PubMed ID: 38780420
[TBL] [Abstract][Full Text] [Related]
16. Rehmannia glutinosa (Gaertn.) DC. polysaccharide ameliorates hyperglycemia, hyperlipemia and vascular inflammation in streptozotocin-induced diabetic mice.
Zhou J; Xu G; Yan J; Li K; Bai Z; Cheng W; Huang K
J Ethnopharmacol; 2015 Apr; 164():229-38. PubMed ID: 25698243
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of multifunctional myricetin for treatment of type 2 diabetes mellitus.
Niisato N; Marunaka Y
Front Nutr; 2023; 10():1175660. PubMed ID: 37305094
[TBL] [Abstract][Full Text] [Related]
18. [A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus].
Ozawa H; Murai Y; Ozawa T
Yakushigaku Zasshi; 2003; 38(1):11-27. PubMed ID: 14570054
[TBL] [Abstract][Full Text] [Related]
19. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
20. Mushroom polysaccharides with potential in anti-diabetes: Biological mechanisms, extraction, and future perspectives: A review.
Liu X; Luo D; Guan J; Chen J; Xu X
Front Nutr; 2022; 9():1087826. PubMed ID: 36590224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
